Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > Are Stocks Still Worthwhile Investments?

Tags

  • combination
  • patients
  • discount
  • developing combination
  • developing combination
  • mutual funds

  • Links

  • You Could Learn a Lot from a Fairy Godmother - How Disney Renewed my Faith in Loyalty and Marketing
  • Generate Residual Income Through Real Estate- Buy Foreclosures
  • What Would Jesus Invest In?
  • Top Articles - Are Stocks Still Worthwhile Investments?

    There is no doubt that a rapid market decline can engender fear and cause investors to sell into the decline. I myself had been selling some stock prior to
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    the fall in order to diversify my assets, as I was fully invested in stocks for some time before the price decline. I even bought a small amount of puts bef
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    re and into the drop, though not enough to offset the fall of the paper value of my portfolio.

    I am still 85% invested in stocks and mutual funds, and stil
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    l believe in the long run. The long term record of the stock market says to do so.

    I believe the stock market will find its bottom in the coming months and
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    hold its value if not resume its advance in the intermediate term. The Dow average will likely find technical support at the 200 day moving average (Dow 118
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    0), though could slice through this support into a selling climax.

    A caveat here is the direction of interest rates. Should the discount rate continue to b
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    e increased, that could tip us into a bear market. Many a bull market has been stymied by a series of discount rate increases, though it often affects the m
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    rket with the time lag. A series of discount rate decreases would be extremely constructive. In general our market has been very resilient over the last ser
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    es of incremental interest rate increases.

    Many people are pointing to a "debacle" in sub prime mortgage loans as a possible threat to the banking system a
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    nd to our stock market. You may recall the savings and loan crisis which reverberated through our banking system and stock market in the late 1980's and ear
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    y 1990's. This crisis was portrayed by bank failures, plummeting bank share prices, and a real estate collapse. This was enough to cause a general bear mark
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    t, punctuated by Saddam Hussein's invasion of Kuwait. The factor of today's sub prime lending and the "crisis" mentality which is being daily discussed on f
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    inancial television everyday is just not enough, in my opinion, to bring the system down. The only thing that could affect the economy and equities would b
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    for the authorities to starve the system of providing mortgage money to potential borrowers - in other words, a credit crunch.

    All the fishing for stock m
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    rket direction aside, the stock market has been a wealth building machine since the depths of the Great Depression. Super bull markets may last as long as t
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    wo decades, followed by periods of sideways to down markets. This is plenty of time to make money in good stocks, or to hold mutual funds through thick and
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    Debt - China and the Risk of Systemic Market Panic, to gain insight into what systemic event could cause stocks to surrender their investment value


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/102103/toparticles-Are-Stocks-Still-Worthwhile-Investments.html">Are Stocks Still Worthwhile Investments?</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/102103/toparticles-Are-Stocks-Still-Worthwhile-Investments.html]Are Stocks Still Worthwhile Investments?[/url]

    Related Articles:

    Energizing Your Internal Audit Program

    You Know Internet Marketing Is for You When

    Credit Repair

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com